calmafusion (calmasol-440) innrennslislyf, lausn 380mg/60mg/50 mg/ml
interchemie werken de adelaar eesti as - calcium gluconate monohydrate; magnesium chloride hexahydrate; boric acid - innrennslislyf, lausn - 380mg/60mg/50 mg/ml
akeega
janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - stækkun Æxli, gelding-Þola - Æxlishemjandi lyf - treatment of adult patients with prostate cancer.
dailiport hart forðahylki 5 mg
sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 5 mg
ibandronic acid wh filmuhúðuð tafla 50 mg
williams & halls ehf - ibandronate sodium monohydrate - filmuhúðuð tafla - 50 mg
dailiport hart forðahylki 0,5 mg
sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 0,5 mg
dailiport hart forðahylki 1 mg
sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 1 mg
dailiport hart forðahylki 2 mg
sandoz a/s - tacrolimus; tacrolimus monohydrate - hart forðahylki - 2 mg
dailiport hart forðahylki 3 mg
sandoz a/s - tacrolimus monohydrate; tacrolimus - hart forðahylki - 3 mg
ibandronic acid wh filmuhúðuð tafla 150 mg
williams & halls ehf - ibandronate sodium monohydrate - filmuhúðuð tafla - 150 mg
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.